Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

Korean listed company 950260950260

Korean listed company 950260 (950260) Material Information, 2026-09-28

Filing date ·

The company will receive $5,000,000 from Eyebiotech Limited, a Merck subsidiary, as a milestone payment for initiating a global Phase 3 clinical trial for diab…

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.